関連する実験動画
Updated: May 4, 2026
08:17
Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
13.9K
心不全およびエジェクション分数の減少を有する患者の左束分岐ブロックに関連したタンパク質バイオマーカー
Karin Ljung1,2, Christian Vestman1,2, Ulrika Reistam1,2
1Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden.
ESC heart failure
|February 19, 2026
まとめ
発射率低下心不全 (HFrEF) の左バンドルブランクブロック (LBBB) は,FGF2およびEGFRを含む血タンパク質を変化させます. このプロテオミックシフトは,LBBBを持つHFrEF患者の心臓リモデリングを誘導する可能性があります.
科学分野:
- 心臓病学 心臓病学
- プロテオミクス プロテオミクスは,プロテオミクスの
- バイオケミストリー バイオケミストリー
背景:
- 左バンドルブランクブロック (LBBB) は,心不全の減少エジェクション分数 (HFrEF) で一般的であり,心不協和症を引き起こし,改造を加速します.
- LBBBに関連した心臓の改造の基礎となる生物学的メカニズムは完全に理解されていません.
研究 の 目的:
- LBBBなしのHFrEF患者とHFrEF患者との比較で,HFrEFとLBBBの患者におけるプラズマタンパク質を調査する.
- HFrEF + LBBBで調節不能なタンパク質と経路を特定し,心臓の改造に潜在的に貢献します.
主な方法:
- 慢性心不全におけるTAILED トリートメントに関するBIOLOGY STUDYの4254人の患者のコホートを分析した.
- HFrEFとLBBBを有する268人の患者 (症例) と,LBBBのないHFrEFを有する268人の患者 (対照群) を,傾向スコアマッチングを用いてマッチングした.
- 364種類のタンパク質の相対性プラズマ濃度は,近接拡張試験を用いてグループ間で比較された.
主要な成果:
- 評価されたタンパク質の11% (41/364) は,HFrEF - LBBBと比較して,HFrEF + LBBBで変化した発現を示した.
- 発現が変化した主要なタンパク質には,線維芽細胞成長因子2 (FGF2) の低下と表皮成長因子受容体 (EGFR) の増加が含まれています.
- 上調されたタンパク質は,免疫応答,細胞シグナル伝達,およびミトゲン活性化タンパク質キナーゼ (MAPK) 経路に関連する経路で濃縮された.
結論:
- HFrEFにおける左束分岐ブロックは,独特の循環タンパク質と関連しています.
- FGF2,EGFR,およびMAPK経路の調節不良は,HFrEF + LBBBにおける加速された心臓リモデルの病理生理学的役割を果たす可能性があります.
- これらの発見は,HFrEFにおけるLBBBに関連する心臓リモデルのバイオマーカーと治療目標の特定のための基礎を提供します.
キーワード:
バイオマーカー バイオマーカーディシンクロニー (Dysynchrony) とは心不全は,心不全によるものです.左のバンドル ブランチブロックプロテオミクス プロテオミクスは,プロテオミクスのリモジリング リモジリングさらに関連する動画
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
6.1K
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
803
関連する概念動画
01:17Pathophysiology of Heart Failure
4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
01:22Heart Failure Drugs: β-Blockers
2.7K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.7K
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
765
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
01:29Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
01:26Heart Failure III: Clinical Manifestations
1.2K
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
1.2K